Isolation and expansion of resident cardiac progenitor cells

Expert Review of Cardiovascular Therapy

Volumn 5, Issue 1, 2007, Pages 33-43

  van Vliet, Patrick ^a,b   Sluijter, Joost P G ^a,b   Doevendans, Pieter A ^a,b   Goumans, Marie José ^b  

^a ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiac progenitor cell; Cardiomyocyte proliferation and differentiation; Stem cell therapy

Indexed keywords

ANGIOGENESIS; CELL DIFFERENTIATION; CELL ISOLATION; CELL LOSS; CELL PROLIFERATION; CELL STIMULATION; CELL TYPE; CLINICAL TRIAL; EMBRYONAL TISSUE; ENDOTHELIUM CELL; HEART FUNCTION; HEART INFARCTION; HEART INJURY; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REPAIR; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIGENS, CD31; ANTIGENS, LY; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HEART; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSCRIPTION, GENETIC;

EID: 33846504815     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.5.1.33     Document Type: Review

References (78)

1. American Heart Association, Heart Disease and Stroke Statistics - 2004 Update., TX, USA, American Heart Association, 2003
2. Holmes JW, Borg TK, Covell JW. Structure and mechanics of healing myocardial infarcts. Annu. Rev. Biomed. Eng. 7, 223-253 (2005).
3. Smits AM, van Vliet P, Hassink RJ, Goumans MJ, Doevendans PA. The role of stem cells in cardiac regeneration. J. Cell. Moll. Med. 9(1), 25-36 (2005).
4. Zwaginga JJ, Doevendans P. Stem cell-derived angiogenic/vasculogenic cells: Possible therapies for tissue repair and tissue engineering. Clin. Exp. Pharmacol. Physiol. 30(11), 900-908 (2003).
5. Fukuda K, Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ. Res. 98(8), 1002-1013 (2006).
6. Makino S, Fukuda K, Miyoshi S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103(5), 697-705 (1999).
7. Hakuno D, Fukuda K, Makino S et al. Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors. Circulation 105(3), 380-386 (2002).
8. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105(1), 93-98 (2002).
9. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 410(6829), 701-705 (2001).
10. Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428(6983), 664-668 (2004).
11. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428(6983), 668-673 (2004).
12. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425(6961), 968-973 (2003).
13. Nygren JM, Jovinge S, Breithach M et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10(5), 494-501 (2004).
14. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: The scientific foundations of cardiac repair. J. Clin. Invest. 115(3), 572-583 (2005).
15. Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: Reflections at the 10-year point. Circulation 112(20), 3174-3183 (2005).
16. Menasche P. Skeletal myoblast transplantation for cardiac repair. Expert. Rev. Cardiovasc. Ther. 2(1), 21-28 (2004).
17. Passier R, Mummery C. Origin and use of embryonic and adult stem cells in differentiation and tissue repair. Cardiovasc. Res. 58(2), 324-335 (2003).
18. Moore JC, van Laake LW, Braam SR et al. Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies. Reprod. Toxicol. 20(3), 377-391 (2005).
19. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ. Res. 83(1), 15-26 (1998).
20. Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344(23), 1750-1757 (2001).
21. Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 415(6868), 240-243 (2002).
22. Harvey RP. Patterning the vertebrate heart. Nat. Rev. Genet. 3(7), 544-556 (2002).
23. Olson EN, Schneider MD. Sizing up the heart: Development redux in disease. Genes Dev. 17(16), 1937-1956 (2003).
24. Zaffran S, Frasch M. Early signals in cardiac development. Circ. Res. 91(6), 457-469 (2002).
25. Franco D, Lamers WH, Moorman AF: Patterns of expression in the developing myocardium: Towards a morphologically integrated transcriptional model. Cardiovasc. Res. 38(1), 25-53 (1998).
26. Masino AM, Gallardo TD, Wilcox CA, Olson EN, Williams RS, Garry DJ. Transcriptional regulation of cardiac progenitor cell populations. Circ. Res. 95(4), 389-397 (2004).
27. Cai CL, Liang X, Shi Y et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 5(6), 877-889 (2003).
28. Yang L, Cai CL, Lin L et al. Isl1 Cre reveals a common Bmp pathway in heart and limb development. Development 133(8), 1575-1585 (2006).
29. Laugwitz KL, Moretti A, Lam J et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433(7026), 647-653 (2005).
30. Greider CW. Telomerase activity, cell proliferation, and cancer. Proc. Natl Acad. Sci. USA. 95(1), 90-92 (1998).
31. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183(4), 1797-1806 (1996).
32. Zhou S, Schuetz JD, Bunting KD et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7(9), 1028-1034 (2001).
33. Hierlihy AM, Seale P, Lobe CG, Rudnicki MA, Megeney LA. The post-natal heart contains a myocardial stem cell population. FEBS Lett. 530(1-3), 239-243 (2002).
34. Martin CM, Meeson AP, Robertson SM et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol. 265(1), 262-275 (2004).
35. Pfister O, Mouquet F, Jain M et al. CD31-but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ. Res. 97(1), 52-61 (2005).
36. van de Rijn M., Heimfeld S, Spangrude GJ, Weissman IL. Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc. Natl Acad. Sci. USA. 86(12), 4634-4638 (1989).
37. Ronnstrand L. Signal transduction via the stem cell factor receptor/ c-Kit. Cell Mol. Life Sci. 61(19-20), 2535-2548 (2004).
38. Matsuura K, Nagai T, Nishigaki N et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem. 279(12), 11384-11391 (2004).
39. Oh H, Bradfute SB, Gallardo TD et el. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA 100(21), 12313-12318 (2003).
40. - Cardiac Progenitor Cell Population in Postinfarction LV Remodeling. Stem Cells 24(7), 1779-1788 (2006).
41. Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114(6), 763-776 (2003).
42. Linke A, Moller P, Nurzynska D et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, unproving cardiac function. Proc. Natl Acad. Sci. USA. 102(25), 8966-8971 (2005).
43. Urbanek K, Rota M, Cascapera S et al. Cardiac stem cells possess growth factor-receptor system that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ. Res. 97(7), 663-673 (2005).
44. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in human. Proc. Natl Acad. Sci. USA. 95(15), 8801-8805 (1998).
45. Urbanek K, Quaini F, Tasca G et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl Acad. Sci. USA 100(18), 10440-10445 (2003).
46. Urbanek K, Torella D, Sheikh F et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl. Acad. Sci. USA. 102(24), 8692-8697 (2005).
47. Messina E, De Angelis L, Frati G et al. Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart. Circ. Res. 95(9), 911-921 (2004).
48. Goumans MJ, de Boer TP, Smits A et al. Human cardiac progenitor cells are able to differentiate into cardiomyocytes in vitro. Circulation 112(17), U106 (2005).
49. Heng BC, Haider HK, Sim EK, Cao T, Ng SC. Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Cadiovasc. Res. 62(1), 34-42 (2004).
50. Mummery C, Ward-van Oostwaard D, Doevendans P et al. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 107(21), 2733-2740 (2003).
51. Kehat I, Khimovich L, Caspi O et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22(10), 1282-1289 (2004).
52. Fukuhara S, Tomita S, Yamashiro S et al. Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro. J. Thorac. Cardiovasc. Surg. 125(6), 1470-1480 (2003).
53. Rubart M, Pasumarthi KB, Nakajima H, Soonpaa MH, Nakajima HO, Field LJ. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ. Res. 92(11), 1217-1224 (2003).
54. Azhar M, Schultz JJ, Grupp I et al. Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev. 14(5), 391-407 (2003).
55. Yoon YS, Wecker A, Heyd L et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115(2), 326-338 (2005).
56. Fazel S, Cimini M, Chen L et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116(7), 1865-1877 (2006).
57. Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98(11), 1414-1421 (2006).
58. Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9(9), 1195-1201 (2003).
59. Gnecchi M, He H, Liang OD et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11(4), 367-368 (2005).
60. Gnecchi M, He H, Noiseux N et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 20(6), 661-669 (2006).
61. O'Neill BT, Abel ED. Akt1 in the cardiovascular system: Friend or foe? J. Clin. Invest. 115(8), 2059-2064 (2005).
62. Rosenblatt-Velin N, Lepore MG, Cartoni C, Beermann F, Pedrazzini T. FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes. J. Clin. Invest. 115(7), 1724-1733 (2005).
63. Simons M, Ware JA. Therapeutic angiogenesis in cardiovascular disease. Nat. Rev. Drug Discov. 2(11), 863-871 (2003).
64. Nordlie MA, Wold LE, Simkhovich BZ, Sesti C, Kloner RA. Molecular aspects of ischemic heart disease: Ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy. J. Cardiovasc. Pharmacol. Ther. 11(1), 17-30 (2006).
65. Behfar A, Zingman LV, Hodgson DM et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 16(12), 1558-1566 (2002).
66. Beqqali A, Kloots J, Ward-van Oostwaard D, Mummery C, Passier R. Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. Stem Cells 24(8), 1956-1967 (2006).
67. Yoon YS, Johnson IA, Park JS, Diaz L, Losordo DW. Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol. Cell Biochem. 264(1-2), 63-74 (2004).
68. Lemos PA, Serruys PW, Sousa JE. Drug-eluting stents: Cost versus clinical benefit. Circulation. 107(24), 3003-3007 (2003).
69. Babensee JE, McIntire LV, Mikos AG. Growth factor delivery for tissue engineering. Pharm. Res. 17(5), 497-504 (2000).
70. Zimmermann WH, Melnychenko I, Wasmeier G et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 12(4), 452-458 (2006).
71. Reinecke H, Zhang M, Bartosek T, Murry CE. Survival, integration, and differentiation of cardiomyocyte grafts: A study in normal and injured rat hearts. Circulation. 100(2), 193-202 (1999).
72. Isner JM. Myocardial gene therapy. Nature 415(6868), 234-239 (2002).
73. Chang MG, Tung L, Sekar RB et al. Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation. 113(15), 1832-1841 (2006).
74. Krause DS. Plasticity of marrow-derived stem cells. Gene Ther. 9(11), 754-758 (2002).
75. Quaini F, Urbanek K, Beltrami AP et al. Chimerism of the transplanted heart. N. Engl. J. Med. 346(1), 5-15 (2002).
76. Laflamme MA, Myerson D, Saffitz JE, Murry CE. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ. Res. 90(6), 634-640 (2002).
77. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol. 23(7), 845-856 (2005).
78. Metzger D, Feil R. Engineering the mouse genome by site-specific recombination. Curr. Opin. Biotechnol. 10(5), 470-476 (1999).